Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Mansfield

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Annals of Surgical Oncology|November 12, 2024
Ten-Year Outcome of a Randomized Trial: Cytoreduction and HIPEC with Mitomycin C Versus Oxaliplatin for Appendiceal Neoplasm with Peritoneal DisseminationEdward A Levine, Heidy Cos, Konstantinos I Votanopoulos, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 17, 2020
Tumor Regression Grade in Gastric Cancer After Preoperative TherapyNaruhiko Ikoma, Jeannelyn S Estrella, Mariela Blum Murphy, et al.
Annals of Surgical Oncology|March 24, 2017
Patterns of Initial Recurrence in Gastric Adenocarcinoma in the Era of Preoperative TherapyNaruhiko Ikoma, Hsiang-Chun Chen, Xuemei Wang, et al.
Annals of Surgery|April 1, 2011
Outcomes in pediatric melanoma: comparing prepubertal to adolescent pediatric patientsStacey Moore-Olufemi, Cynthia Herzog, Carla Warneke, et al.
Annals of Surgical Oncology|November 14, 2019
Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and MitomycinOmeed Moaven, Konstantinos I Votanopoulos, Perry Shen, et al.
Annals of Surgical Oncology|October 26, 2016
Race Is a Risk for Lymph Node Metastasis in Patients With Gastric CancerNaruhiko Ikoma, Mariela Blum, Yi-Ju Chiang, et al.
Annals of Surgical Oncology|July 11, 2018
Preoperative Therapy for Gastric Adenocarcinoma is Protective for Poor Oncologic Outcomes in Patients with Complications After GastrectomyDiego Vicente, Naruhiko Ikoma, Yi-Ju Chiang, et al.
Journal of the American College of Surgeons|February 13, 2025
Long-Term Cytoreduction Outcomes With or Without Heated Intraperitoneal Chemotherapy For Colorectal Peritoneal MetastasesMichael G White, Paula Marincola Smith, Neal Bhutiani, et al.
International Journal of Radiation Oncology, Biology, Physics|September 5, 2024
Phase 1 Trial of Total Neoadjuvant Therapy With Short-Course Chemoradiotherapy Followed by Chemotherapy for Patients With Potentially Resectable Gastric CancerBrian Badgwell, Naruhiko Ikoma, Mariela Blum Murphy, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|April 22, 2018
Central Lymph Node Metastasis in Gastric Cancer Is Predictive of Survival After Preoperative TherapyNaruhiko Ikoma, Jeannelyn S Estrella, Mariela Blum, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Annals of Surgical Oncology|November 12, 2024
Ten-Year Outcome of a Randomized Trial: Cytoreduction and HIPEC with Mitomycin C Versus Oxaliplatin for Appendiceal Neoplasm with Peritoneal DisseminationEdward A Levine, Heidy Cos, Konstantinos I Votanopoulos, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 17, 2020
Tumor Regression Grade in Gastric Cancer After Preoperative TherapyNaruhiko Ikoma, Jeannelyn S Estrella, Mariela Blum Murphy, et al.
Annals of Surgical Oncology|March 24, 2017
Patterns of Initial Recurrence in Gastric Adenocarcinoma in the Era of Preoperative TherapyNaruhiko Ikoma, Hsiang-Chun Chen, Xuemei Wang, et al.
Annals of Surgery|April 1, 2011
Outcomes in pediatric melanoma: comparing prepubertal to adolescent pediatric patientsStacey Moore-Olufemi, Cynthia Herzog, Carla Warneke, et al.
Annals of Surgical Oncology|November 14, 2019
Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and MitomycinOmeed Moaven, Konstantinos I Votanopoulos, Perry Shen, et al.
Annals of Surgical Oncology|October 26, 2016
Race Is a Risk for Lymph Node Metastasis in Patients With Gastric CancerNaruhiko Ikoma, Mariela Blum, Yi-Ju Chiang, et al.
Annals of Surgical Oncology|July 11, 2018
Preoperative Therapy for Gastric Adenocarcinoma is Protective for Poor Oncologic Outcomes in Patients with Complications After GastrectomyDiego Vicente, Naruhiko Ikoma, Yi-Ju Chiang, et al.
Journal of the American College of Surgeons|February 13, 2025
Long-Term Cytoreduction Outcomes With or Without Heated Intraperitoneal Chemotherapy For Colorectal Peritoneal MetastasesMichael G White, Paula Marincola Smith, Neal Bhutiani, et al.
International Journal of Radiation Oncology, Biology, Physics|September 5, 2024
Phase 1 Trial of Total Neoadjuvant Therapy With Short-Course Chemoradiotherapy Followed by Chemotherapy for Patients With Potentially Resectable Gastric CancerBrian Badgwell, Naruhiko Ikoma, Mariela Blum Murphy, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|April 22, 2018
Central Lymph Node Metastasis in Gastric Cancer Is Predictive of Survival After Preoperative TherapyNaruhiko Ikoma, Jeannelyn S Estrella, Mariela Blum, et al.
Pageof 9